Kommoss S - Search Results

1

Correction: TERT promoter mutation in adult granulosa cell tumor of the ovary.

Pilsworth JA, Cochrane DR, Xia Z, Aubert G, Färkkilä AEM, Horlings HM, Yanagida S, Yang W, Lim JLP, Wang YK, Bashashati A, Keul J, Wong A, Norris K, Brucker SY, Taran FA, Krämer B, Staebler A, van Meurs H, Oliva E, Shah SP, Kommoss S, Kommoss F, Gilks CB, Baird DM, Huntsman DG. Pilsworth JA, et al. Among authors: kommoss f, kommoss s. Mod Pathol. 2019 Apr;32(4):593. doi: 10.1038/s41379-018-0085-8. Mod Pathol. 2019. PMID: 29968850 Free article.

2

Acidic ascites inhibits ovarian cancer cell proliferation and correlates with the metabolomic, lipidomic and inflammatory phenotype of human patients.

Yang Q, Bae G, Nadiradze G, Castagna A, Berezhnoy G, Zizmare L, Kulkarni A, Singh Y, Weinreich FJ, Kommoss S, Reymond MA, Trautwein C. Yang Q, et al. Among authors: kommoss s. J Transl Med. 2022 Dec 12;20(1):581. doi: 10.1186/s12967-022-03763-3. J Transl Med. 2022. PMID: 36503580 Free PMC article.

3

Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7.

Heublein S, Pfisterer J, du Bois A, Anglesio M, Aminossadati B, Bhatti I, Sehouli J, Wimberger P, Schochter F, Hilpert F, Hillemanns P, Kalder M, Schroeder W, Mahner S, Burges A, Canzler U, Gropp-Meier M, Jackisch C, Harter P, Kommoss S, Marmé F. Heublein S, et al. Among authors: kommoss s. Lab Invest. 2024 Apr;104(4):100321. doi: 10.1016/j.labinv.2023.100321. Epub 2023 Dec 27. Lab Invest. 2024. PMID: 38154497 Clinical Trial.

4

No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group.

Wentzensen N, du Bois A, Kommoss S, Pfisterer J, von Knebel Doeberitz M, Schmidt D, Kommoss F. Wentzensen N, et al. Among authors: kommoss f, kommoss s. Int J Gynecol Pathol. 2008 Jan;27(1):18-23. doi: 10.1097/pgp.0b013e318074b83f. Int J Gynecol Pathol. 2008. PMID: 18156969

5

The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas.

Köbel M, Reuss A, du Bois A, Kommoss S, Kommoss F, Gao D, Kalloger SE, Huntsman DG, Gilks CB. Köbel M, et al. Among authors: kommoss f, kommoss s. J Pathol. 2010 Oct;222(2):191-8. doi: 10.1002/path.2744. J Pathol. 2010. PMID: 20629008

6

Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.

Anglesio MS, Kommoss S, Tolcher MC, Clarke B, Galletta L, Porter H, Damaraju S, Fereday S, Winterhoff BJ, Kalloger SE, Senz J, Yang W, Steed H, Allo G, Ferguson S, Shaw P, Teoman A, Garcia JJ, Schoolmeester JK, Bakkum-Gamez J, Tinker AV, Bowtell DD, Huntsman DG, Gilks CB, McAlpine JN. Anglesio MS, et al. Among authors: kommoss s. J Pathol. 2013 Jan;229(1):111-20. doi: 10.1002/path.4088. J Pathol. 2013. PMID: 22899400

7

FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines.

Kommoss S, Anglesio MS, Mackenzie R, Yang W, Senz J, Ho J, Bell L, Lee S, Lorette J, Huntsman DG, Blake Gilks C. Kommoss S, et al. Mod Pathol. 2013 Jun;26(6):860-7. doi: 10.1038/modpathol.2012.226. Epub 2013 Jan 25. Mod Pathol. 2013. PMID: 23348906 Free article.

8

Ovarian cellular fibromas lack FOXL2 mutations: a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumor.

McCluggage WG, Singh N, Kommoss S, Huntsman DG, Gilks CB. McCluggage WG, et al. Among authors: kommoss s. Am J Surg Pathol. 2013 Sep;37(9):1450-5. doi: 10.1097/PAS.0b013e31828e4f55. Am J Surg Pathol. 2013. PMID: 23774170

9

Accelerating type-specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (COSP) is a reliable high-throughput tool for case review.

Kommoss S, Gilks CB, Kommoss F, Chow C, Hilpert F, du Bois A, Köbel M, Huntsman DG, Anglesio M, Kalloger SE, Pfisterer J. Kommoss S, et al. Among authors: kommoss f. Histopathology. 2013 Nov;63(5):704-12. doi: 10.1111/his.12219. Epub 2013 Sep 2. Histopathology. 2013. PMID: 24033430

10

A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary.

Kommoss S, Gilks CB, Penzel R, Herpel E, Mackenzie R, Huntsman D, Schirmacher P, Anglesio M, Schmidt D, Kommoss F. Kommoss S, et al. Among authors: kommoss f. Histopathology. 2014 Feb;64(3):380-8. doi: 10.1111/his.12253. Epub 2013 Nov 6. Histopathology. 2014. PMID: 24192202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

142 results

Search Page